Difference between revisions of "Assessment Procedure Guidance"

From QIBA Wiki
Jump to navigation Jump to search
Line 1: Line 1:
 +
This Guidance supplements the [[Profile Template]] and the [[Claim Guidance]] by describing the process of developing appropriate procedures to assess profile requirements, particularly those related to the performance assumptions underlying the claim (e.g. the repeatability coefficient for the volumes generated by the tumor segmentation software).
 +
*[[Media:GuidanceConformance_ClaimStatisticalAssumptions-2017.05.03.docx|QIBA Assessment Procedure Guidance]] ''2017.05.03'' DRAFT
 +
 
<THIS IS STILL A DRAFT UNDER DEVELOPMENT - Should be ready 2017Q2 >
 
<THIS IS STILL A DRAFT UNDER DEVELOPMENT - Should be ready 2017Q2 >
 
Section 4 of the Profile contains procedures for assessing requirements from Section 3 that cannot be assessed by direct observation or some other simple method.
 
 
This material supplements the [[Profile Template]] and the [[Claim Guidance]] by describing the process of developing appropriate procedures to assess such requirements, particularly those related to the performance assumptions underlying the claim (e.g. the repeatability coefficient for the volumes generated by the tumor segmentation software).
 
*[[Media:GuidanceConformance_ClaimStatisticalAssumptions-2017.05.03.docx|QIBA Assessment Procedure Guidance]] ''2017.05.03'' DRAFT
 
  
  
==Suggestions==
+
===Suggestions===
Submit suggested improvements/gaps by adding bullets here:
+
Submit suggested improvements/gaps in this document by adding bullets here:
 
:*
 
:*
  
 
They will be reviewed by the Process Committee and addressed in upcoming versions.
 
They will be reviewed by the Process Committee and addressed in upcoming versions.
  
==Past Versions==
+
===Past Versions===
 +
*[[Media:Minimum Requirements Claim Testing-10-12-2014.pdf|Minimum Requirements Claim Testing]] ''October 2014''

Revision as of 04:32, 10 May 2017

This Guidance supplements the Profile Template and the Claim Guidance by describing the process of developing appropriate procedures to assess profile requirements, particularly those related to the performance assumptions underlying the claim (e.g. the repeatability coefficient for the volumes generated by the tumor segmentation software).

<THIS IS STILL A DRAFT UNDER DEVELOPMENT - Should be ready 2017Q2 >


Suggestions

Submit suggested improvements/gaps in this document by adding bullets here:

They will be reviewed by the Process Committee and addressed in upcoming versions.

Past Versions